Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14356/1231
Title: | Post COVID-19 vaccine Guillain-Barré syndrome |
Authors: | khadka, Bikash Khanal, Kishor |
Citation: | khadkaB., & KhanalK. (2022). Post COVID-19 vaccine Guillain-Barré syndrome. Journal of Nepal Health Research Council, 19(04), 852-854. https://doi.org/10.33314/jnhrc.v19i04.3803 |
Issue Date: | 2021 |
Publisher: | Nepal Health Research Council |
Article Type: | Case Report |
Keywords: | Guillain-Barré syndrome immunoglobulin jansen vaccine polyneuropathy |
Series/Report no.: | Oct-Dec, 2021;3803 |
Abstract: | Abstract Guillain-Barré syndrome is an acute generalized polyneuropathy which usually follows infection with a virus or bacteria, although rarely vaccination may be associated with it. We present a case of a 44-year-man who presented with progressive weakness of both lower limbs since 6?days, neurological examination findings were consistent with flaccid-type paraplegia and investigation findings including lumbar puncture and nerve conduction studies were consistent with the diagnosis of Guillain-Barré syndrome. He had received the Johnson and Johnson corona virus disease-19 vaccine intramuscularly 15 days before his presentation. Only potential triggering factor in this case was positive finding of Jansen Vaccine. Keywords: Guillain-Barré syndrome; immunoglobulin; jansen vaccine; polyneuropathy. |
Description: | Case Report |
URI: | http://103.69.126.140:8080/handle/20.500.14356/1231 |
ISSN: | Print ISSN: 1727-5482; Online ISSN: 1999-6217 |
Appears in Collections: | Vol. 19 No. 04 (2021): Vol 19 No 4 Issue 53 Oct-Dec 2021 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
3803-Manuscript-26809-1-10-20220313.pdf | Fulltext Download | 478.18 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.